Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...

Danish pharmaceutical giant Novo Nordisk (NYSE:NVO) is watching its stock plummet 20% in morning trading after slashing its ...

Hundreds of tenants from across Massachusetts descended on Beacon Hill Tuesday to show their support for rent stabilization ...

Novo Nordisk A/S named its head of international operations as chief executive officer after slumping weight-loss drug sales led to a profit warning that wiped $93 billion off its market value.

The Trump administration has pledged to curb rising obesity with school meal reforms and artificial dye bans, though the ...

Eli Lilly stock slips after Novo Nordisk trims 2025 forecast; Jaypirca meets endpoint in CLL trial against J&J's Imbruvica, ...

Experts say supplement companies have tried to capitalize on the GLP-1 craze, putting the phrase in their product names, ...

Section 1.10.32 of "de Finibus Bonorum et Malorum", written by Cicero in 45 BC ...

GLP-1 receptor agonists are an important drug class and have become widely popular due to their effectiveness in weight ...

Copenhagen-listed shares of Novo Nordisk plunged more than 21% on Tuesday after the Danish pharmaceutical company issued a profit warning, citing weaker-than-expected sales growth for its flagship ...

The Danish firm blamed the move to slash its guidance on intense competition from rivals and copycat drugs in the US.

Wall Street chugged mostly higher in premarket trading as Chinese and U.S. officials begin a second day of trade talks.